ILLUMINARE BIOTECHNOLOGIES
Illuminare Biotechnologies is a operator of a biotechnology company intended to reduce risk of nerve damage during surgery. The company is currently operating under stealth mode.
ILLUMINARE BIOTECHNOLOGIES
Industry:
Biotechnology Health Care Medical Device
Founded:
2016-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.illuminarebio.com
Total Employee:
1+
Status:
Active
Contact:
6094971282
Email Addresses:
[email protected].
Total Funding:
2.37 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Apache GoDaddy DNS GoDaddy GoDaddy Email
Similar Organizations
Evren Technologies
Evren Technologies focuses on developing wearable products treatment for PTSD and trauma-related issues through discreet.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Kintai Therapeutics
Kintai is a biotechnology company that advancing precision therapeutics based on enteric signaling networks in the human body.
Micell Technologies
Micell Technologies is a biomedical device company developing interventional cardiology systems for vascular drug delivery.
Current Employees Featured
Founder
Official Site Inspections
http://www.illuminarebio.com
- Host name: 237.114.180.107.host.secureserver.net
- IP address: 107.180.114.237
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Illuminare Biotechnologies"
Illuminare Biotechnologies - Crunchbase Company Profile & Funding
Organization. Illuminare Biotechnologies . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]. …See details»
Illuminare Biotechnologies - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Illuminare Biotechnologies. Use the PitchBook Platform to explore the full profile.See details»
Illuminare Biotechnologies Company Profile | Management and
Www.illuminarebio.com Illuminare Biotechnologies Profile and History Our proprietary lead candidate, Illuminare-1, is a small molecule with an immediate onset of action and sustained …See details»
Illuminare Biotechnologies - Overview, News & Similar ... - ZoomInfo
Jan 23, 2023 Illuminare Biotechnologies contact info: Phone number: (609) 497-1282 Website: www.illuminarebio.com What does Illuminare Biotechnologies do? Our proprietary lead …See details»
Illuminare-1, A Novel Nerve Visualization Investigational …
May 25, 2021 Illuminare Biotechnologies is a privately held clinical-stage biotechnology company founded in 2016 to develop Illuminare-1. For more information about the Company, …See details»
Illuminare Biotechnologies Overview - Salary.com
The trusted data and intuitive software your organization needs to get pay right. Explore CompAnalyst ... illuminarebio.com. View Complete Information. Hot Search Keywords for …See details»
Illuminare Biotechnologies, Inc. - Drug pipelines, Patents, Clinical ...
Explore Illuminare Biotechnologies, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 3 news.See details»
ILLUMINARE, INC. Company Profile | Los Angeles, CA
Find company research, competitor information, contact details & financial data for ILLUMINARE, INC. of Los Angeles, CA. Get the latest business insights from Dun & Bradstreet.See details»
Beta How much do Illuminare Biotechnologies employees make?
The average annual salary of Illuminare Biotechnologies is estimated to be approximate $84,031 per year. The majority pay is between $74,662 to $93,652 per year. Visit Salary.com to find …See details»
Illuminare Biotechnologies Chief Executive Officer Salaries
The average annual Chief Executive Officer salary is estimated to be approximately $875,133 per year. The majority pay is between $670,795 to $1,101,497 per year. Visit Salary.com to find …See details»
Novel Nerve Visualization Investigational Fluorophore Receives …
NEW YORK, April 15, 2021 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved Illuminare-1, a small molecule, myelin binding agent, for their Investigational New …See details»
Illuminare Biotechnologies Chief Medical Officer Salaries
The average annual Chief Medical Officer salary is estimated to be approximately $479,463 per year. The majority pay is between $425,767 to $544,919 per year. Visit Salary.com to find out …See details»
Illuminare-1, A Novel Nerve Visualization Investigational …
NEW YORK, May 25, 2021 /PRNewswire/ — Illuminare Biotechnologies, a clinical-stage biotechnology company, announced that its novel nerve imaging agent, Illuminare-1, has been …See details»
illuminare biotechnologies, inc. News & Press Releases - PR …
Apr 15, 2021 News from illuminare biotechnologies, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, …See details»
FDA grants fast track status to Illuminare-1, a nerve imaging agent
May 27, 2021 The FDA granted fast track designation to Illuminare-1, a novel nerve visualization agent that locates and delineates nerves during surgery to avoid nerve injury, according to a …See details»
Illuminare Biotechnologies Salary for Board Member BETA
The average annual Illuminare Biotechnologies Salary for Board Member is estimated to be approximately $102,856 per year. The majority pay is between $80,412 to $124,085 per year. …See details»
Liberate Bio, Inc. Company Profile | Boston, MA | Competitors ...
Find company research, competitor information, contact details & financial data for Liberate Bio, Inc. of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
Isolere Bio Company Profile 2024: Valuation, Investors ... - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for Isolere Bio. Use the PitchBook Platform to explore the full profile.See details»
Illuminare Biotechnologies Salary for Chief Financial Officer
The average annual Illuminare Biotechnologies Salary for Chief Financial Officer is estimated to be approximately $456,256 per year. The majority pay is between $350,534 to $571,778 per …See details»
Illuminare Biotechnologies Announces First Participant Dosed in …
Jan 23, 2023 Illuminare-1 is a single dose injectable myelin binding fluorescent agent currently in development by Illuminare Biotechnologies, in collaboration with MSK, to provide real time …See details»